Go compare with our comparison table

New shares tempt investors at TD Waterhouse

23 October 2009 / by Rebecca Sargent

TD Waterhouse saw new entries into it's top ten charts last week, as new stocks accounted for 31 per cent of top ten trades.

Pharmaceuticals featured heavily in the charts as investors tracked recent developments in the pharmaceutical sector. Angus Rigby, chief executive at TD Waterhouse comments:

"Large pharmaceutical company stocks are traditionally regarded as defensive due to inelastic demand for health care products, but smaller stocks are more popular with adventurous investors."

And, as TD Waterhouse share dealing customers showed interest in two small biotch companies, it "suggests they were injecting some risk into their portfolios."

British biotech firm Phytopharm made number seven in the top ten last week, following its promising early test results with it's Parkinson's disease drug that has pushed the company's share price up by 350 per cent.

In fact, Phytopharm stocks accounted for nearly eight per cent of the top ten trades, with a buy to sell ratio of 1.5 to 1, which directly mirrors the overall top ten buy too sell ratio.

Overall, investors at TD Waterhouse seem to be replenishing their stocks, Mr Rigby adds: "This week's top ten trades suggest our customers have been looking to refresh their investment portfolios with new stocks entering the tables from other sectors also."

Oil and gas companies and Punch taverns, the leading British pub group, also featured heavily.

Click to learn more about TD Waterhouse share dealing »

© Fair Investment Company Ltd


ProviderAccountTrade From:OnlineMore Info
£12.50 per online tradeyesMore Info >
£9.95 per online tradeyesMore Info >

The value of your investments can rise as well as fall. You may get back less than you invested. If you’re unsure, we recommend you ask for independent advice.